Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Three Amigos Stock Thread -- Ignore unavailable to you. Want to Upgrade?

To: Ken W who wrote (28617)	5/25/2002 10:33:15 AM
From: Sergio H	Read Replies (1) \| Respond to of 29382

Very interesting Ken. Without any opinion as to guilt in this particular case, my thought is that we're entering into a paranoia era. Thanks for the link. What's your opinon? Worthwhile list from today's Barron's: Company Price 52 Mkt. Net Net Book / Earnings as of 5/23 Week Value Cash Cash Value Hi - Lo Share Share Comments Abgenix 14.30 47 - 11 1.24 0.44 $ 5.00 $ 8.70 -$1.59 Hurt by psoriasis drug failure Arena Pharm 7.75 36 - 7 0.21 0.22 8.00 9.74 -0.97 Cash-rich gene tech. firm Avigen 9.68 24 - 7 0.19 0.14 7.00 7.50 -1.60 Focused on hemophilia cure Celera Genomics 14.89 50 - 12 1.02 0.91 13.35 16.15 -1.51 Gene mapper now drug creator Curagen 8.21 42 - 7 0.39 0.33 6.70 6.90 -1.87 Another cash-rich gene firm CV Therapeutics 24.93 61 - 21 0.64 0.26 10.00 11.50 -4.22 Angina drug could be lucrative Human Genome 17.96 77 - 13 2.30 1.10 8.50 9.70 -1.41 Using genomics to find drugs ImClone Systems 10.50 76 - 9 0.77 0.18 2.40 -0.40 -1.29 CEO of Erbitux maker just quit Intermune 28.50 53 - 21 0.90 0.26 8.50 8.90 -3.60 Fibrosis drug has big potential Maxygen 10.47 23 - 9 0.36 0.23 6.90 7.45 -1.08 Multiple sclerosis drug in works Medarex 10.41 33 - 7 0.77 0.28 3.74 6.25 -0.59 Asset-rich antibody producer Millenium Pharm 17.95 45 - 15 5.02 1.30 5.20 11.80 -0.73 Merged with Cor Therapeutics Oxford Glycosciences 5.80 17 - 4 0.32 0.26 4.70 5.11 -0.70 Working on Gaucher disease Praecis Pharm 3.11 32 - 2 0.16 0.26 5.00 5.30 -1.53 Cash exceeds market value Protein Design Lab 13.05 46 - 10 1.15 0.49 5.30 6.05 -0.20 Focused on antibody therapy Transkaryotic Ther 41.09 47 - 22 1.41 0.37 11.00 12.25 -2.10 Promising Fabry disease drug